When MDC1 was analyzed in B-ALL cell lines after Plk1 siRNN treatment (Fig. 4A), the mRNA analysis indicated a trend towards a stepwise increase of MDC1 as the Plk1 mRNA decreased. The gene discussed is MDC1; the disease is acute lymphoblastic leukemia.